News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
404,350 Results
Type
Article (25262)
Company Profile (163)
Press Release (378925)
Multimedia
Podcasts (87)
Webinars (14)
Section
Business (121971)
Career Advice (1111)
Deals (26944)
Drug Delivery (106)
Drug Development (55376)
Employer Resources (89)
FDA (9307)
Job Trends (9449)
News (217793)
Policy (20267)
Tag
Academia (1082)
Accelerated approval (8)
Adcomms (20)
Allergies (54)
Alliances (32217)
ALS (73)
Alzheimer's disease (785)
Antibody-drug conjugate (ADC) (130)
Approvals (9338)
Artificial intelligence (259)
Autoimmune disease (26)
Automation (10)
Bankruptcy (220)
Best Places to Work (6929)
BIOSECURE Act (13)
Biosimilars (117)
Biotechnology (81)
Bladder cancer (54)
Brain cancer (28)
Breast cancer (197)
Cancer (1766)
Cardiovascular disease (153)
Career advice (920)
Career pathing (25)
CAR-T (92)
CDC (9)
Cell therapy (244)
Cervical cancer (15)
Clinical research (46862)
Collaboration (730)
Company closure (1)
Compensation (258)
Complete response letters (27)
COVID-19 (1374)
CRISPR (39)
C-suite (245)
Cystic fibrosis (76)
Data (1952)
Decentralized trials (2)
Denatured (22)
Depression (46)
Diabetes (219)
Diagnostics (2744)
Digital health (16)
Diversity (8)
Diversity, equity & inclusion (28)
Drug discovery (124)
Drug pricing (138)
Drug shortages (33)
Duchenne muscular dystrophy (85)
Earnings (46979)
Editorial (38)
Employer branding (10)
Employer resources (84)
Events (55727)
Executive appointments (618)
FDA (10357)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (549)
Gene editing (81)
Generative AI (27)
Gene therapy (220)
GLP-1 (725)
Government (2313)
Grass and pollen (3)
Guidances (127)
Healthcare (8376)
HIV (29)
Huntington's disease (17)
IgA nephropathy (36)
Immunology and inflammation (119)
Immuno-oncology (10)
Indications (29)
Infectious disease (1486)
Inflammatory bowel disease (107)
Inflation Reduction Act (10)
Influenza (35)
Intellectual property (91)
Interviews (158)
IPO (9263)
IRA (50)
Job creations (2787)
Job search strategy (807)
Kidney cancer (8)
Labor market (37)
Layoffs (360)
Leadership (18)
Legal (4984)
Liver cancer (41)
Longevity (9)
Lung cancer (269)
Lymphoma (152)
Machine learning (7)
Management (32)
Manufacturing (332)
MASH (63)
Medical device (4547)
Medtech (4550)
Mergers & acquisitions (18238)
Metabolic disorders (668)
Multiple sclerosis (71)
NASH (20)
Neurodegenerative disease (76)
Neuropsychiatric disorders (29)
Neuroscience (1255)
NextGen: Class of 2025 (3241)
Non-profit (1518)
Now hiring (30)
Obesity (390)
Opinion (215)
Ovarian cancer (46)
Pain (97)
Pancreatic cancer (74)
Parkinson's disease (115)
Partnered (15)
Patents (209)
Patient recruitment (90)
Peanut (21)
People (37550)
Pharmaceutical (80)
Pharmacy benefit managers (25)
Phase I (14570)
Phase II (19957)
Phase III (15975)
Pipeline (1200)
Policy (175)
Postmarket research (1758)
Preclinical (5349)
Press Release (32)
Prostate cancer (94)
Psychedelics (20)
Radiopharmaceuticals (187)
Rare diseases (343)
Real estate (3665)
Recruiting (32)
Regulatory (14647)
Reports (31)
Research institute (1105)
Resumes & cover letters (184)
Rett syndrome (8)
RNA editing (5)
RSV (33)
Schizophrenia (83)
Series A (106)
Series B (62)
Service/supplier (9)
Sickle cell disease (43)
Special edition (18)
Spinal muscular atrophy (121)
Sponsored (16)
Startups (2418)
State (2)
Stomach cancer (10)
Supply chain (63)
Tariffs (64)
The Weekly (63)
Vaccines (408)
Venture capital (43)
Weight loss (272)
Women's health (20)
Worklife (9)
Date
Today (62)
Last 7 days (234)
Last 30 days (1174)
Last 365 days (19621)
2025 (10847)
2024 (21321)
2023 (23425)
2022 (31059)
2021 (32371)
2020 (30496)
2019 (25302)
2018 (19761)
2017 (20396)
2016 (19103)
2015 (22118)
2014 (17347)
2013 (14691)
2012 (15732)
2011 (16157)
2010 (14920)
Location
Africa (498)
Alabama (31)
Alaska (2)
Arizona (97)
Arkansas (10)
Asia (28755)
Australia (3880)
California (3916)
Canada (1555)
China (514)
Colorado (160)
Connecticut (185)
Delaware (124)
Europe (60399)
Florida (687)
Georgia (99)
Hawaii (1)
Idaho (29)
Illinois (368)
India (23)
Indiana (248)
Iowa (5)
Japan (197)
Kansas (71)
Kentucky (26)
Louisiana (9)
Maine (13)
Maryland (526)
Massachusetts (3174)
Michigan (96)
Minnesota (197)
Mississippi (2)
Missouri (41)
Montana (14)
Nebraska (13)
Nevada (33)
New Hampshire (21)
New Jersey (1550)
New Mexico (22)
New York (1133)
North Carolina (754)
North Dakota (4)
Northern California (1627)
Ohio (128)
Oklahoma (7)
Oregon (23)
Pennsylvania (942)
Puerto Rico (16)
Rhode Island (25)
South America (750)
South Carolina (12)
Southern California (1569)
Tennessee (95)
Texas (535)
United States (15536)
Utah (97)
Virginia (126)
Washington D.C. (59)
Washington State (328)
West Virginia (3)
Wisconsin (42)
404,350 Results for "addrenex pharmaceuticals acquired by sciele pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Torrent Pharma to Acquire Controlling Stake in J. B. Chemicals & Pharmaceuticals from KKR
June 30, 2025
·
6 min read
Clinical research
Undeterred by Political, Economic Headwinds, Pharma Ups R&D Investment in 2024 and Beyond
R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.
May 28, 2025
·
12 min read
·
Tristan Manalac
Press Releases
Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK
Antev Shareholders to Receive Aggregate ~17% Equity Stake in Medicus plus US$65 Million in Contingent Payments
June 30, 2025
·
10 min read
Press Releases
ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction
July 15, 2025
·
13 min read
Press Releases
Gensco Pharma® Acquires Global Rights and IP for RizaFilm® and RizaPort®
May 14, 2025
·
4 min read
Press Releases
Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals
June 9, 2025
·
8 min read
Opinion
How AI and Genetics Could Restore Public Trust in Pharma
Slashing adverse drug reactions through pharmacogenetics and advanced AI could help rehabilitate the pharmaceutical industry’s reputation amid mounting criticism.
July 7, 2025
·
6 min read
·
Allan Gobbs
Press Releases
Sun Pharma to Acquire Checkpoint Therapeutics
March 10, 2025
·
24 min read
Press Releases
Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade
July 9, 2025
·
17 min read
Press Releases
Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team
July 3, 2025
·
2 min read
1 of 40,435
Next
